Statins and contrast-induced acute kidney injury with coronary angiography

American Journal of Medicine

Volumn 127, Issue 10, 2014, Pages 987-1000

  Gandhi, Sumeet ^a   Mosleh, Wassim ^b   Abdel Qadir, Husam ^c,d   Farkouh, Michael E ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

angiogram; atorvastatin; CIN; contrast induced acute kidney injury; contrast induced nephropathy; coronary angiography; PCI; percutaneous coronary intervention; rosuvastatin; simvastatin statins

Indexed keywords

CONTRAST MEDIUM; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG EFFICACY; DRUG MEGADOSE; HEMODIALYSIS; HUMAN; LOW DRUG DOSE; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT RISK; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; ACUTE KIDNEY INJURY; BIBLIOGRAPHIC DATABASE; CHEMICALLY INDUCED; CHRONIC KIDNEY FAILURE; COMPLICATION; HEART FAILURE; PROTECTION;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; DATABASES, BIBLIOGRAPHIC; DIABETES COMPLICATIONS; HEART FAILURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PERCUTANEOUS CORONARY INTERVENTION; PROTECTIVE FACTORS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84907963940     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.05.011     Document Type: Article

References (54)

1. K. Nash, A. Hafeez, and S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 5 2002 930 936
2. L. Gruberg, R. Mehran, and G. Dangas Acute renal failure requiring dialysis after percutaneous coronary interventions Catheter Cardiovas Interv 52 4 2001 409 416
3. S.D. Weisbord, and P.M. Palevsky Contrast-induced acute kidney injury: short- and long-term implications Semin Nephrol 31 3 2011 300 309
4. P.A. McCullough, R. Wolyn, L.L. Rocher, R.N. Levin, and W.W. O'Neill Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality Am J Med 103 5 1997 368 375
5. R. Lencioni, R. Fattori, G. Morana, and F. Stacul Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study Acta Radiol 51 7 2010 741 750
6. R.E. Katholi, W.T. Woods Jr., and G.J. Taylor Oxygen free radicals and contrast nephropathy Am J Kidney Dis 32 1 1998 64 71
7. I. Goldenberg, and S. Matetzky Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies CMAJ 172 11 2005 1461 1471
8. J. Tumlin, F. Stacul, and A. Adam Pathophysiology of contrast-induced nephropathy Am J Cardiol 98 6A 2006 14K 20K
9. D. Russo, R. Minutolo, B. Cianciaruso, B. Memoli, G. Conte, and L. De Nicola Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure J Am Soc Nephrol 6 5 1995 1451 1458
10. A.M. Kelly, B. Dwamena, P. Cronin, S.J. Bernstein, and R.C. Carlos Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy Ann Intern Med 148 4 2008 284 294
11. Z. Sun, Q. Fu, L. Cao, W. Jin, L. Cheng, and Z. Li Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials PLoS One 8 1 2013 e55124
12. R. Mehran, E. Nikolsky, and A.J. Kirtane Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study JACC Cardiovasc Interv 2 5 2009 415 421
13. E. Adolph, B. Holdt-Lehmann, and T. Chatterjee Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy Coron Artery Dis 19 6 2008 413 419
14. M. Maioli, A. Toso, and M. Leoncini Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention J Am Coll Cardiol 52 8 2008 599 604
15. T. Zhang, L.H. Shen, L.H. Hu, and B. He Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis Am J Nephrol 33 4 2011 344 351
16. R. Pappy, S. Stavrakis, T.A. Hennebry, and M.S. Abu-Fadel Effect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysis Int J Cardiol 151 3 2011 348 353
17. Y. Li, Y. Liu, L. Fu, C. Mei, and B. Dai Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials PLoS One 7 4 2012 e34450
18. Y. Han, G. Zhu, and L. Han Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease J Am Coll Cardiol 63 1 2014 62 70
19. M. Leoncini, A. Toso, M. Maioli, F. Tropeano, S. Villani, and F. Bellandi Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome. Results from Protective effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome (PRATO-ACS Study) J Am Coll Cardiol 63 1 2014 71 79
20. C. Quintavalle, D. Fiore, and F. De Micco Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury Circulation 126 25 2012 3008 3016
21. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 7 2009 e1000097
22. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 1996 1 12
23. R.D. Riley, J.P. Higgins, and J.J. Deeks Interpretation of random effects meta-analyses BMJ 342 2011 d549
24. S. Khanal, N. Attallah, and D.E. Smith Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions Am J Med 118 8 2005 843 849
25. P. Kandula, R. Shah, N. Singh, S.J. Markwell, N. Bhensdadia, and S.D. Navaneethan Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention Nephrology (Carlton) 15 2 2010 165 170
26. J.Z. Su, Y. Xue, and W.Q. Cai Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin [Chinese] Zhonghua Xin Xue Guan Bing Za Zhi 39 9 2011 807 811
27. S. Yoshida, H. Kamihata, and S. Nakamura Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency J Cardiol 54 2 2009 192 198
28. A. Bouzas-Mosquera, J.M. Vazquez-Rodriguez, R. Calvino-Santos, N. Vazquez-Gonzalez, and A. Castro-Beiras Statin therapy and contrast-induced nephropathy after primary angioplasty Int J Cardiol 134 3 2009 430 431
29. G. Patti, A. Nusca, and M. Chello Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention Am J Cardiol 101 3 2008 279 285
30. N. Attallah, L. Yassine, J. Musial, J. Yee, and K. Fisher The potential role of statins in contrast nephropathy Clin Nephrol 62 4 2004 273 278
31. H. Takagi, and T. Umemoto A meta-analysis of randomized trials for effects of periprocedural atorvastatin on contrast-induced nephropathy Int J Cardiol 153 3 2011 323 325
32. L. Zhang, Y. Lu, and B. Wu Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials Int J Clin Pract 65 5 2011 624 630
33. W.J. Liu, B.C. Zhang, R. Guo, Y.D. Wei, W.M. Li, and Y.W. Xu Renoprotective effect of alprostadil in combination with statins in patients with mild to moderate renal failure undergoing coronary angiography Chin Med J (Engl) 126 18 2013 3475 3480
34. S. Cao, P. Wang, K. Cui, L. Zhang, and Y. Hou Atorvastatin prevents contrast agent-induced renal injury in patients undergoing coronary angiography by inhibiting oxidative stress [Chinese] Nan Fang Yi Ke Da Xue Xue Bao 32 11 2012 1600 1602
35. G.L. Chen, and J.Z. Su Atorvastatin attenuated contrast induced renal function damage [Chinese] Zhonghua Xin Xue Guan Bing Za Zhi 37 5 2009 389 393
36. M.A. Munoz, P.R. Maxwell, K. Green, D.W. Hughes, and R.L. Talbert Pravastatin versus simvastatin for prevention of contrast-induced nephropathy J Cardiovasc Pharmacol Ther 16 3-4 2011 376 379
37. A. Toso, M. Leoncini, and M. Maioli Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction J Cardiovasc Med (Hagerstown) 12 5 2011 318 321
38. X. Zhou, Y.Z. Jin, Q. Wang, R. Min, and X.Y. Zhang Efficacy of high dose atorvastatin on preventing contrast induced nephropathy in patients underwent coronary angiography [Chinese] Zhonghua Xin Xue Guan Bing Za Zhi 37 5 2009 394 396
39. S.-H. Jo, J.-Y. Hahn, and S.Y. Lee High dose atorvastatin pretreatment for preventing contrast-induced nephropathy in patients receiving primary percutaneous coronary intervention: prespecified substudy of a prospective randomized clinical trial Am J Cardiol 111 7 2013 95B 96B
40. Y. Miao, and Z. Yu-Jie Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention Heart 97 Suppl 3 2011 A229
41. W. Li, X. Fu, and Y. Wang Beneficial effects of high-dose atorvastatin pretreatment on renal function in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention Cardiology 122 3 2012 195 202
42. S.H. Jo, B.K. Koo, and J.S. Park Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial - a randomized controlled study Am Heart J 155 3 2008 499.e1 499.e8
43. H. Ozhan, I. Erden, and S. Ordu Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography Angiology 61 7 2010 711 714
44. G. Patti, E. Ricottini, and A. Nusca Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty - contrast-induced nephropathy] trial) Am J Cardiol 108 1 2011 1 7
45. A. Toso, M. Maioli, and M. Leoncini Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease Am J Cardiol 105 3 2010 288 292
46. J. Xinwei, F. Xianghua, and Z. Jing Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention Am J Cardiol 104 4 2009 519 524
47. M.S. de Oliveira, K.B.A. Martins, and J.R. Costa Jr. Impact on renal function of rosuvastatin preload prior to elective percutaneous coronary intervention in chronic statin users Rev Bras Cardiol Invasiva 20 2012 303 308
48. S.J. Ha, J.W. Kim, and T.K. Yoo Usefulness of statin pretreatment to prevent contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention in real world Eur Heart J 32 Suppl 1 2011 935 1118
49. S. Acikel, H. Muderrisoglu, and A. Yildirir Prevention of contrast-induced impairment of renal function by short-term or long-term statin therapy in patients undergoing elective coronary angiography Blood Coagul Fibrinolysis 21 8 2010 750 757
50. G. Marenzi, G. Lauri, and E. Assanelli Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction J Am Coll Cardiol 44 9 2004 1780 1785
51. C.G. Mihos, M.J. Salas, and O. Santana The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review Cardiol Rev 18 6 2010 298 304
52. A.H. Wagner, T. Kohler, U. Ruckschloss, I. Just, and M. Hecker Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation Arterioscler Thromb Vasc Biol 20 1 2000 61 69
53. T. Ichiki, K. Takeda, and T. Tokunou Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells Arterioscler Thromb Vasc Biol 21 12 2001 1896 1901
54. K.K. Ray, and C.P. Cannon Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology Curr Opin Lipidol 15 6 2004 637 643